Coloplast A/S (OTCMKTS:CLPBY – Get Free Report) saw a large decline in short interest during the month of July. As of July 15th, there was short interest totalling 79,700 shares, a decline of 12.1% from the June 30th total of 90,700 shares. Based on an average daily trading volume, of 134,500 shares, the short-interest ratio is currently 0.6 days.
Coloplast A/S Price Performance
OTCMKTS:CLPBY traded up $0.10 during trading hours on Wednesday, reaching $12.96. 44,062 shares of the company’s stock were exchanged, compared to its average volume of 55,532. Coloplast A/S has a 1-year low of $9.90 and a 1-year high of $14.34. The company has a quick ratio of 0.39, a current ratio of 0.60 and a debt-to-equity ratio of 0.71. The company has a 50-day moving average of $12.38 and a 200 day moving average of $12.64.
Coloplast A/S (OTCMKTS:CLPBY – Get Free Report) last posted its earnings results on Tuesday, May 7th. The company reported $0.08 EPS for the quarter, meeting the consensus estimate of $0.08. The firm had revenue of $959.05 million for the quarter. Coloplast A/S had a return on equity of 36.74% and a net margin of 19.45%. On average, sell-side analysts predict that Coloplast A/S will post 0.34 earnings per share for the current year.
Coloplast A/S Cuts Dividend
Coloplast A/S Company Profile
Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments.
Further Reading
- Five stocks we like better than Coloplast A/S
- The 3 Best Fintech Stocks to Buy Now
- Joby Aviation Stock: The Case for Upside Just Got Stronger
- Overbought Stocks Explained: Should You Trade Them?
- Conviction Firms for Microsoft’s Double-Digit Stock Upside
- Are Penny Stocks a Good Fit for Your Portfolio?
- 5 Aggressive Growth Stocks for Long-Term Investors
Receive News & Ratings for Coloplast A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Coloplast A/S and related companies with MarketBeat.com's FREE daily email newsletter.